Meloxicam is a staple analgesic in today’s companion animal practice.
Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, anti-exudative, analgesic and antipyretic effects. It reduces leukocyte infiltration into the inflamed tissue.
Reliven® borrows from Alfaxan® technology to update and improve the formulation for easy syringeability andcomfortable administration.
Solubilised in hydroxypropylcyclodextrin (HPCD), Reliven is easier to syringe and more comfortable to inject
- Meloxicam 5 mg/mL
Dogs: For alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders. For reduction of post-operative pain and inflammation following orthopaedic and soft tissue surgery in dogs.
Cats: For reduction of pain after surgery. For management of febrile conditions in combination with appropriate antibiotics.
Musculoskeletal disorders: Single subcutaneous injection at a dosage of 0.2 mg meloxicam / kg bodyweight (i.e. 0.4 mL / 10 kg bodyweight). An oral meloxicam product should be used for continuation of treatment at a dosage of 0.1 mg meloxicam / kg bodyweight, 24 hours after administration of the injection.
Reduction of post-operative pain: Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam / kg bodyweight (i.e. 0.4 mL / 10 kg bodyweight) before surgery, for example at the time of induction of anaesthesia.
Reduction of post-operative pain: Single subcutaneous injection at a dosage of 0.3 mg meloxicam / kg bodyweight (i.e. 0.06 mL / kg bodyweight) directly prior to induction of anaesthesia.
Management of febrile conditions: Single subcutaneous injection at a dosage of 0.3 mg meloxicam / kg bodyweight (i.e. 0.06 mL / kg bodyweight).